Skip to main content
Log in

ACE inhibitors still pivotal in the management of proteinuric nephropathies

  • Disease Management
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Pisoni R, Ruggenenti P, Remuzzi G. Renoprotective therapy in patients with nondiabetic nephropathies. Drugs 2001: 61 (6): 733–45

    Article  PubMed  CAS  Google Scholar 

  2. Incidence and prevalence of ESRD. United States Renal Data System. Am J Kidney Dis 1998; 32 (2 Suppl. 1): S38–49

    Google Scholar 

  3. Remuzzi G, Ruggenenti P, Benigni A. Understanding the nature of renal disease progression. Kidney Int 1997; 51: 2–15

    Article  PubMed  CAS  Google Scholar 

  4. GISEN Group. Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. Lancet 1997; 349: 1857–63

    Article  Google Scholar 

  5. Peterson JC, Adler S, Burkart JM, et al. Blood pressure control, proteinuria, and the progression of renal disease. Modification of Diet in Renal Disease. Ann Intern Med 1995; 123: 754–62

    PubMed  CAS  Google Scholar 

  6. Mallick NP, Short CD, Hunt LP. How far since Ellis? Nephron 1987; 46: 113–24

    Article  PubMed  CAS  Google Scholar 

  7. Remuzzi A, Perticucci E, Ruggenenti P, et al. Angiotensin converting enzyme inhibition improves glomerular size-selectivity in IgA nephropathy. Kidney Int 1991; 39: 1267–73

    Article  PubMed  CAS  Google Scholar 

  8. Maschio G, Alberti D, Janin G, et al. Effect of the angiotensin-converting enzyme inhibitor benazepril on the progression of chronic renal insufficiency. N Engl J Med 1996; 334: 939–45

    Article  PubMed  CAS  Google Scholar 

  9. Ruggenenti P, Perna A, Benini R, et al. In chronic nephropathies prolonged ACE inhibition can induce remission: dynamics of time-dependent changes in GFR. J Am Soc Nephrol 1999; 10: 997–1006

    PubMed  CAS  Google Scholar 

  10. Ruggenenti P, Perna A, Zoccali C, et al. Chronic proteinuric nephropathies. Outcomes and response to treatment in a prospective cohort of 352 patients: differences between women and men in relation to ACE gene polymorphism. J Am Soc Nephrol 2000; 11: 88–96

    PubMed  CAS  Google Scholar 

  11. Bakris GL, Weir MR. Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine. Arch Intern Med 2000; 160: 685–93

    Article  PubMed  CAS  Google Scholar 

  12. Smith AC, Toto R, Bakris GL. Differential effects of calcium channel blockers on size selectivity of proteinuria in diabetic glomerulopathy. Kidney Int 1998; 54: 889–96

    Article  PubMed  CAS  Google Scholar 

  13. Zoccali C, Valvo E, Russo D, et al. Antiproteinuric effect of losartan in patients with chronic renal diseases [letter]. Nephrol Dial Transplant 1997; 12: 234–5

    Article  PubMed  CAS  Google Scholar 

  14. Russo D, Pisani A, Balletta MM, et al. Additive antiproteinuric effect of converting enzyme inhibitor and losartan in normotensive patients with IgA nephropathy. Am J Kidney Dis 1999; 33: 851–6

    Article  PubMed  CAS  Google Scholar 

  15. Bakris GL, Weir MR, De Quattro V, et al. Effects of an ACE inhibitor/calcium antagonist combination on proteinuria in diabetic nephropathy. Kidney Int 1998; 54: 1283–9

    Article  PubMed  CAS  Google Scholar 

  16. Perico N, Remuzzi A, Sangalli F, et al. The antiproteinuric effect of angiotensin antagonism in human IgA nephropathy is potentiated by indomethacin. J Am Soc Nephrol 1998; 9: 2308–17

    PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

ACE inhibitors still pivotal in the management of proteinuric nephropathies. Drugs Ther. Perspect 18, 8–11 (2002). https://doi.org/10.2165/00042310-200218020-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-200218020-00004

Keywords

Navigation